Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Over the last 12 months, insiders at Bruker Corporation have bought $0 and sold $7.49M worth of Bruker Corporation stock.
On average, over the past 5 years, insiders at Bruker Corporation have bought $98,167 and sold $21.97M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,710 shares for transaction amount of $98,559 was made by LAUKIEN FRANK H (PRESIDENT & CEO) on 2022‑05‑11.
2024-03-04 | Sale | Requardt Hermann Fritz | director | 15,000 0.0109% | $90.06 | $1.35M | -13.19% | |
2024-02-28 | Sale | Busse Falko | PRESIDENT, BIOSPIN GROUP | 28,122 0.0201% | $85.48 | $2.4M | -9.17% | |
2024-02-22 | Sale | Prause Burkhard | PRES. & CEO, BRUKER BEST | 15,319 0.011% | $83.30 | $1.28M | -3.76% | |
2023-08-08 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 37,947 0.0256% | $64.81 | $2.46M | +6.88% | |
2023-06-16 | Sale | Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | 14,242 0.0097% | $75.42 | $1.07M | -5.26% | |
2023-05-19 | Sale | Kastner Marc A | director | 11,146 0.0075% | $75.22 | $838,402 | -5.22% | |
2023-05-16 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 14,625 0.0099% | $73.11 | $1.07M | -2.03% | |
2023-05-15 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 185,375 0.1269% | $72.75 | $13.49M | -0.56% | |
2023-05-09 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 110,982 0.0745% | $75.20 | $8.35M | -5.58% | |
2023-05-08 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 89,018 0.0606% | $77.05 | $6.86M | -6.67% | |
2023-05-03 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 16,435 0.0111% | $79.21 | $1.3M | -10.26% | |
2023-05-02 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 100,770 0.0684% | $77.98 | $7.86M | -7.97% | |
2023-05-01 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 82,795 0.0565% | $78.75 | $6.52M | -8.29% | |
2023-04-25 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 51,770 0.0361% | $78.86 | $4.08M | -6.37% | |
2023-04-24 | Sale | LAUKIEN FRANK H | PRESIDENT & CEO | 148,230 0.1008% | $81.02 | $12.01M | -11.27% | |
2023-01-17 | Sale | Friend Cynthia M | director | 921 0.0006% | $68.26 | $62,867 | +5.18% | |
2022-12-06 | Sale | PACKER RICHARD A | director | 20,000 0.0134% | $66.18 | $1.32M | +5.67% | |
2022-11-15 | Sale | Kastner Marc A | director | 10,000 0.0069% | $70.75 | $707,490 | +2.07% | |
2022-05-11 | LAUKIEN FRANK H | PRESIDENT & CEO | 1,710 0.0012% | $57.64 | $98,559 | +16.39% | ||
2022-02-18 | Sale | LAUKIEN FRANK H | CEO, President | 26,790 0.0177% | $68.51 | $1.84M | -7.54% |
LAUKIEN FRANK H | PRESIDENT & CEO | 38217344 27.6115% | $65.30 | 88 | 16 | +27.04% |
Busse Falko | PRESIDENT, BIOSPIN GROUP | 32859 0.0237% | $65.30 | 0 | 1 | |
Requardt Hermann Fritz | director | 23147 0.0168% | $65.30 | 0 | 1 | |
Prause Burkhard | Pres. & CEO, Bruker EST | 17065 0.016% | $65.30 | 0 | 4 | |
LAUKIEN DIRK D | 15862972 11.4608% | $65.30 | 1 | 7 | ||
LAUKIEN JOERG C | 15208795 10.9881% | $65.30 | 4 | 7 | +23.29% | |
LAUKIEN MARC M | 10 percent owner | 14506348 10.4806% | $65.30 | 1 | 4 | |
LAUKIEN ISOLDE | 10 percent owner | 14160160 10.2305% | $65.30 | 1 | 3 | |
Srega Juergen | Group President Bruker CALID | 130936 0.0946% | $65.30 | 0 | 1 | |
WAGNER CHARLES F JR | EVP & Chief Financial Officer | 99925 0.0722% | $65.30 | 0 | 1 | |
Munch Mark | Exec VP&Pres Bruker Nano Inc. | 85064 0.0615% | $65.30 | 0 | 5 | |
KNIGHT WILLIAM J | Chief Financial Officer | 63350 0.0458% | $65.30 | 3 | 0 | +60.54% |
PACKER RICHARD A | director | 59907 0.0433% | $65.30 | 2 | 2 | +5.57% |
KNISS RICHARD | director | 40753 0.0294% | $65.30 | 0 | 2 | |
Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | 36462 0.0263% | $65.30 | 0 | 1 | |
LINTON WILLIAM A | director | 29000 0.021% | $65.30 | 1 | 0 | +24.86% |
Martin Gilles Gerard Jean | director | 14657 0.0106% | $65.30 | 0 | 1 | |
Friend Cynthia M | director | 11576 0.0084% | $65.30 | 0 | 7 | |
Lenggenhager Rene | President, BioSpin Group | 11037 0.008% | $65.30 | 0 | 1 | |
Kastner Marc A | director | 8051 0.0058% | $65.30 | 0 | 6 | |
VAN INGEN CHRIS | director | 4577 0.0033% | $65.30 | 0 | 2 | |
STEIN RICHARD M | Secretary | 3349 0.0024% | $65.30 | 0 | 2 | |
FURLONG BRENDA J | director | 1000 0.0007% | $65.30 | 0 | 1 | |
Fesik Stephen W. | director | 0 0% | $65.30 | 0 | 1 | |
Emmerich Wolf-Dieter | director | 0 0% | $65.30 | 0 | 1 |
T Rowe Price Investment Management Inc | $1.25B | 9.13 | 13.27M | +0.61% | +$7.62M | 0.76 | |
The Vanguard Group | $926.29M | 6.79 | 9.86M | -0.37% | -$3.41M | 0.02 | |
BlackRock | $912.56M | 6.68 | 9.71M | -1.11% | -$10.25M | 0.02 | |
Pallas Capital Advisors | $890.6M | 6.52 | 9.48M | +12.52% | +$99.12M | 40.05 | |
Fidelity Investments | $861.58M | 6.31 | 9.17M | -2.76% | -$24.49M | 0.06 | |
Massachusetts Financial Services Co Ma | $759.87M | 5.57 | 8.09M | +0.11% | +$826,390.18 | 0.23 | |
RTW Investments, LP | $314.14M | 2.3 | 3.34M | 0% | +$0 | 4.64 | |
State Street | $305.11M | 2.24 | 3.25M | +2.87% | +$8.51M | 0.01 | |
AllianceBernstein | $243.69M | 1.79 | 2.59M | +7.31% | +$16.6M | 0.09 | |
Invesco | $196.35M | 1.44 | 2.09M | +5.32% | +$9.92M | 0.04 | |
Fuller & Thaler Asset Management, Inc. | $195.14M | 1.43 | 2.08M | +10.01% | +$17.75M | 0.85 | |
London Co Of Virginia | $170.67M | 1.25 | 1.82M | +33,101.17% | +$170.15M | 0.9 | |
Td Asset Management Inc | $168.04M | 1.23 | 1.79M | +7.45% | +$11.65M | 0.15 | |
Geode Capital Management | $157.17M | 1.15 | 1.67M | +1.81% | +$2.79M | 0.01 | |
Brown Advisory | $145.15M | 1.06 | 1.55M | -2.83% | -$4.23M | 0.19 | |
Citadel Advisors LLC | $140.86M | 1.03 | 1.5M | -4.34% | -$6.39M | 0.09 | |
Congress Asset Management Co Ma | $132.87M | 0.97 | 1.41M | +3.46% | +$4.44M | 0.96 | |
Dimensional Fund Advisors | $110.45M | 0.81 | 1.18M | +0.42% | +$465,660.43 | 0.03 | |
Bank of America | $109.68M | 0.8 | 1.17M | +21.55% | +$19.45M | 0.01 | |
T. Rowe Price | $99.73M | 0.73 | 1.06M | -22.71% | -$29.3M | 0.01 | |
Goldman Sachs | $97.53M | 0.71 | 1.04M | -41.79% | -$70.02M | 0.02 | |
BNY Mellon | $88.13M | 0.65 | 938,199 | -3.64% | -$3.33M | 0.02 | |
Janus Henderson | $81.65M | 0.6 | 869,205 | +3.52% | +$2.78M | 0.05 | |
Ameriprise Financial | $76.57M | 0.56 | 815,075 | -7.41% | -$6.13M | 0.02 | |
First Trust | $76.65M | 0.56 | 815,897 | +13,343.68% | +$76.08M | 0.08 | |
Charles Schwab | $70.43M | 0.52 | 749,742 | +0.26% | +$182,243.60 | 0.02 | |
Morgan Stanley | $70.24M | 0.51 | 747,704 | +2.31% | +$1.59M | 0.01 | |
Marshall Wace | $57.3M | 0.42 | 609,988 | New | +$57.3M | 0.07 | |
Northern Trust | $56.82M | 0.42 | 604,834 | -13.11% | -$8.57M | 0.01 | |
Palisade Capital Management | $49M | 0.36 | 521,633 | -6.04% | -$3.15M | 1.46 | |
Iron Triangle Partners LP | $43.82M | 0.32 | 466,521 | +3.67% | +$1.55M | 4.54 | |
Epoch Investment Partners Inc | $43.86M | 0.32 | 466,865 | +15.15% | +$5.77M | 0.2 | |
Handelsbanken | $43.05M | 0.32 | 458,300 | +18.03% | +$6.58M | 0.19 | |
Alyeska Investment Group L P | $40.82M | 0.3 | 434,568 | -22% | -$11.51M | 0.26 | |
Montanaro Asset Management | $38.14M | 0.28 | 406,000 | -12.74% | -$5.57M | 6.89 | |
Colorado PERA | $33.65M | 0.25 | 358,200 | -1.06% | -$360,256.60 | 0.15 | |
Brown Brothers Harriman Co | $32.97M | 0.24 | 350,998 | +34.7% | +$8.49M | 0.25 | |
Vaughan Nelson Investment Management | $31.26M | 0.23 | 332,728 | +5.56% | +$1.65M | 0.28 | |
DekaBank | $28.69M | 0.21 | 307,040 | +0.6% | +$172,298.45 | 0.05 | |
Nuveen | $27.48M | 0.2 | 292,510 | -2.84% | -$802,811.26 | 0.01 | |
RhumbLine Advisers | $26.62M | 0.2 | 283,365 | -6.48% | -$1.84M | 0.03 | |
Grantham Mayo Van Otterloo & Co LLC | $24.95M | 0.18 | 265,583 | +29.7% | +$5.71M | 0.09 | |
AQR Capital | $23.21M | 0.17 | 248,447 | -6.34% | -$1.57M | 0.04 | |
New York State Common Retirement Fund | $21.83M | 0.16 | 232,361 | -4.93% | -$1.13M | 0.03 | |
Integral Health Asset Management Llc | $20.67M | 0.15 | 220,000 | +120% | +$11.27M | 2.05 | |
Eventide Asset Management | $19.76M | 0.15 | 210,362 | <0.01% | -$281.82 | 0.31 | |
Envestnet Asset Management Inc | $19.05M | 0.14 | 202,824 | +7.79% | +$1.38M | 0.01 | |
JPMorgan Chase | $18.95M | 0.14 | 201,710 | -7.24% | -$1.48M | <0.01 | |
CalPERS | $17.69M | 0.13 | 188,310 | -4.54% | -$840,762.98 | 0.01 | |
Legal & General | $17.51M | 0.13 | 186,347 | -9.88% | -$1.92M | <0.01 |